Genome-wide association study (GWASs) have shown that CDKN2BAS gene variants are associated with the risk of multiple diseases comprising type 2 diabetes [20,21], ischemic stroke [22], CHD [17,19], and periodontitis [23] that is prone to develop CHD [23]. This evidence concerns the gene CDKN2B-AS1 and ischemic stroke.